PL356565A1 - Pochodne aminosulfonylobifenylu - Google Patents

Pochodne aminosulfonylobifenylu

Info

Publication number
PL356565A1
PL356565A1 PL01356565A PL35656501A PL356565A1 PL 356565 A1 PL356565 A1 PL 356565A1 PL 01356565 A PL01356565 A PL 01356565A PL 35656501 A PL35656501 A PL 35656501A PL 356565 A1 PL356565 A1 PL 356565A1
Authority
PL
Poland
Prior art keywords
aminosulfonylbiphenyl
derivatives
aminosulfonylbiphenyl derivatives
Prior art date
Application number
PL01356565A
Other languages
English (en)
Inventor
Dieter Dorsch
Horst Juraszyk
Werner Mederski
Christos Tsaklakidis
Sabine Bernotat-Danielowski
Guido Melzer
Johannes Gleitz
Christopher Barnes
James Vickers
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL356565A1 publication Critical patent/PL356565A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL01356565A 2000-02-23 2001-02-22 Pochodne aminosulfonylobifenylu PL356565A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008329A DE10008329A1 (de) 2000-02-23 2000-02-23 Aminosulfonylbiphenylderivate
PCT/EP2001/002034 WO2001062717A1 (de) 2000-02-23 2001-02-22 Aminosulfonylbiphenylderivate

Publications (1)

Publication Number Publication Date
PL356565A1 true PL356565A1 (pl) 2004-06-28

Family

ID=7632028

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01356565A PL356565A1 (pl) 2000-02-23 2001-02-22 Pochodne aminosulfonylobifenylu

Country Status (19)

Country Link
US (1) US20030135055A1 (pl)
EP (1) EP1257530A1 (pl)
JP (1) JP2003524651A (pl)
KR (1) KR20020091092A (pl)
CN (1) CN1404467A (pl)
AU (1) AU2001254661A1 (pl)
BR (1) BR0108607A (pl)
CA (1) CA2399018A1 (pl)
CZ (1) CZ20022783A3 (pl)
DE (1) DE10008329A1 (pl)
HK (1) HK1052499A1 (pl)
HU (1) HUP0300008A2 (pl)
MX (1) MXPA02008207A (pl)
NO (1) NO20023998D0 (pl)
PL (1) PL356565A1 (pl)
RU (1) RU2002123337A (pl)
SK (1) SK11992002A3 (pl)
WO (1) WO2001062717A1 (pl)
ZA (1) ZA200205482B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030141B2 (en) 2001-11-29 2006-04-18 Christopher Franklin Bigge Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
DE10204072A1 (de) * 2002-01-31 2003-08-14 Morphochem Ag Komb Chemie Neue Verbindungen, die Faktor Xa-Aktivität inhibieren
AU2004309357B2 (en) * 2003-12-22 2010-10-07 Merck Sharp & Dohme Corp. Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
KR20140018997A (ko) 2005-01-07 2014-02-13 신타 파마슈티칼스 코프. 염증 및 면역 관련 용도를 위한 화합물
TW200806641A (en) 2006-01-25 2008-02-01 Synta Pharmaceuticals Corp Substituted aromatic compounds for inflammation and immune-related uses
US7816535B2 (en) 2006-01-25 2010-10-19 Synta Pharmaceuticals Corp. Vinyl-phenyl derivatives for inflammation and immune-related uses
US8044242B2 (en) 2006-03-09 2011-10-25 Bristol-Myers Squibb Company 2-(aryloxy) acetamide factor VIIa inhibitors useful as anticoagulants
CN101583593A (zh) 2006-11-13 2009-11-18 辉瑞产品公司 二芳基、二吡啶基和芳基-吡啶基衍生物及其用途
KR20200123866A (ko) 2007-02-09 2020-10-30 메타베이시스 테라퓨틱스, 인크. 글루카곤 수용체의 길항제
PT2799428T (pt) 2008-08-13 2017-02-17 Metabasis Therapeutics Inc Antagonistas de glicagina
WO2015191900A1 (en) 2014-06-12 2015-12-17 Ligand Pharmaceuticals, Inc. Glucagon antagonists
WO2019160940A1 (en) 2018-02-13 2019-08-22 Ligand Pharmaceuticals Incorporated Glucagon receptor antagonists
CN116585297B (zh) * 2023-06-28 2025-06-06 云南大学附属医院 一种磺酰胺类衍生物的应用
WO2026019701A1 (en) * 2024-07-15 2026-01-22 Venenum Biodesign, LLC Substituted phenylsulfonamides as mgat2 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69720773T2 (de) * 1996-12-23 2004-01-29 Bristol Myers Squibb Pharma Co SAUERSTOFF ODER SCHWEFEL ENTHALTENDE 5-GLIEDRIGE HETEROAROMATISHE DERIVATIVE ALS FACTOR Xa HEMMER
KR20010082515A (ko) * 1998-02-17 2001-08-30 우에노 도시오 아미디노 유도체 및 그 유도체를 유효 성분으로서함유하는 약제
AU5283700A (en) * 1999-05-24 2000-12-12 Cor Therapeutics, Inc. Inhibitors of factor xa
CA2374947A1 (en) * 1999-05-24 2000-11-30 Robert M. Scarborough Inhibitors of factor xa

Also Published As

Publication number Publication date
WO2001062717A1 (de) 2001-08-30
JP2003524651A (ja) 2003-08-19
SK11992002A3 (sk) 2003-01-09
CZ20022783A3 (cs) 2002-11-13
AU2001254661A1 (en) 2001-09-03
ZA200205482B (en) 2003-12-31
RU2002123337A (ru) 2004-01-10
CN1404467A (zh) 2003-03-19
CA2399018A1 (en) 2001-08-30
KR20020091092A (ko) 2002-12-05
NO20023998L (no) 2002-08-22
NO20023998D0 (no) 2002-08-22
BR0108607A (pt) 2002-11-19
US20030135055A1 (en) 2003-07-17
HK1052499A1 (zh) 2003-09-19
DE10008329A1 (de) 2001-08-30
MXPA02008207A (es) 2002-11-29
EP1257530A1 (de) 2002-11-20
HUP0300008A2 (hu) 2003-06-28

Similar Documents

Publication Publication Date Title
EG22695A (en) Novel phenyl-propargylether derivatives
AU6053701A (en) 2-aminocarbonyl-9h-purine derivatives
HRP20030055A2 (en) 4-phenyl-pyridine derivatives
IL150841A0 (en) 1h-imidazopyridine derivatives
DE50112082D1 (en) Bulk-acoustic-wave-filter
DE60128102D1 (en) Imidazolderivate
GB0019073D0 (en) Microconnector
IL155103A0 (en) Substituted c-cyclohexylmethylamine derivatives
PL356565A1 (pl) Pochodne aminosulfonylobifenylu
DE50112014D1 (en) Stiftheizer
HUP0300562A3 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the
AU6619001A (en) Liquid-pourers
IL150557A0 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives
AU8993701A (en) Substituted 1-aminobutan-3-ol derivatives
DE50114303D1 (en) Nsaugluftkanal
IL150558A0 (en) Aminomethyl-phenyl-cyclohexanone derivatives
AU9187601A (en) Triazolo-epothilones
AU2163202A (en) 5-amino-1-pentene-3-ol substituted derivatives
IL151598A0 (en) 2-phenylpyran-4-one derivatives
GB0021639D0 (en) Maurotoxin derivatives
SI1246793T1 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives
SI1322590T1 (sl) Substituirani 5-amino-1-penten-3-olni derivati
AU2117P (en) Gauka Gaura lindheimeri
AU1702P (en) Trailblazer Xanthostemon chrysanthus
AU143712S (en) Colpotomiser

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)